Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial.
Eur Respir J. 2021 Jul 8;58(1):2003725. doi: 10.1183/13993003.03725-2020. Print 2021 Jul.
Eur Respir J. 2021.
PMID: 33361100
Free PMC article.
Clinical Trial.